# Safety Study of Erythropoietin (EPO) in Parkinson's Disease

> **NCT01010802** · PHASE1 · COMPLETED · sponsor: **International Center for Neurological Restoration, Cuba** · enrollment: 10 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Erythropoietin human recombinant (EPOrh)

## Key facts

- **NCT ID:** NCT01010802
- **Lead sponsor:** International Center for Neurological Restoration, Cuba
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010802, "Safety Study of Erythropoietin (EPO) in Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01010802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*